Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Yida Pharmaceutical Co., Ltd. is a pharmaceutical enterprise based in Liaoyuan, Jilin Province, China, specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company operates modern production facilities that are fully compliant with national Good Manufacturing Practice (GMP) standards, producing a variety of dosage forms including tablets, capsules, and granules. Its commercial portfolio primarily addresses therapeutic areas such as cardiovascular health, infectious diseases, and respiratory conditions. Notable products include Compound Salvia Miltiorrhiza tablets and various antibiotic formulations like Amoxicillin and Norfloxacin. Jilin Yida focuses on the domestic Chinese market, leveraging its integrated manufacturing capabilities to provide essential and affordable medications. The company is recognized for its efforts in modernizing traditional herbal treatments through standardized extraction and formulation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Jilin Yida Pharmaceutical.